Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT04277377
Nanoparticle for DSA Removal
Sponsor: University of Zurich
View on ClinicalTrials.gov
Summary
Magnetic nanoparticles, coated with human leukocyte antigens (HLA) to capture anti-HLA antibodies with donor specificity (donor-specific antibodies, DSA), will be tested ex-vivo.
Official title: Donor-specific Anti-human Leukocyte Antigen Antibodies (DSA) Re-moval From Patient Blood Using Functionalized Nanoparticles - an ex Vivo Feasibility and Proof of Principle Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2021-10-05
Completion Date
2026-02-28
Last Updated
2025-08-28
Healthy Volunteers
No
Locations (1)
University Hospital Zurich, Division of Anaesthesiology
Zurich, Canton of Zurich, Switzerland